[Click here to JOIN and get our WEEKLY newsletter!!]

CIMA LABS Announces Second - Quarter 2003 Financial Results
Business Wire (press release) - Jul 31, 2003
... CIMA operated at full capacity during the second quarter, as our sales
of Remeron SolTabs and Alavert to CIMA's partners remained strong. ...

Teva Pharmaceutical Industries "underperform"
New Ratings - Jul 30, 2003
... Copaxone. Q3 earnings are likely to be hurt by increased competition
in the anti-depressant Remeron market, the analyst adds. On ...

Bitter Orange Could Mean Red Alert With Some Drugs
Newsday - Jul 29, 2003
... effects. Q. I've been taking Wellbutrin and Remeron for severe depression.
But lately I've developed paranoid thoughts and feelings. ...

Drug treatment shows promise against sleep apnea
Chicago Sun Times, IL - Jul 23, 2003
... The researchers monitored sleep patterns of 12 people with sleep apnea, who each
were given the drug, an antidepressant called Remeron, and, at a different time ...

Akzo Nobel upgraded to " buy " - update
New Ratings - Jul 21, 2003
... measures. The analysts say that Remeron’s sales are down and further
margin pressure can be limited with effective cost cuts. ...

Drugs giants find generic competition a bitter pill to swallow
Scotland on Sunday, UK - Jul 19, 2003
... But the loss of patent protection on Remeron, its top-selling anti-depressant,
has sent the unit’s first-half operating profits down 13%. ...

Akzo hints at separating pharma division
Financial Times (subscription), UK - Jul 18, 2003
... But the loss of patent protection on Remeron, its top-selling antidepressant,
sent the unit's first-half operating profits down 13 per cent. ...

Akzo Shares Rise as 2nd-Qtr Profit Beats Estimates (Update5)
Bloomberg - Jul 18, 2003
... news. Akzo has turned to cost cutting as its biggest selling drug,
the antidepressant Remeron, loses sales to cheaper generics. ...

Akzo Shares Rise as 2nd-Qtr Profit Beats Estimates (Update4)
Bloomberg - Jul 18, 2003
... news. Akzo has turned to cost cutting as its biggest selling drug,
the antidepressant Remeron, loses sales to cheaper generics. ...

Akzo Shares Rise as 2nd-Qtr Profit Beats Estimates (Update3)
Bloomberg - Jul 18, 2003
... news. Akzo has turned to cost cutting as its biggest selling drug,
the antidepressant Remeron, loses sales to cheaper generics. ...

Akzo Shares Rise as 2nd-Qtr Profit Beats Estimates (Update2)
Bloomberg - Jul 18, 2003
... news. Akzo has turned to cost cutting as its biggest selling drug,
the antidepressant Remeron, loses sales to cheaper generics. ...

Akzo Nobel's quarterly profits slide
... currencies and pensions. Pharma sales were impacted by generic competition
to our key drug Remeron in the United States. Net income ...

Akzo Shares Rise as 2nd-Qtr Profit Beats Estimates (Update1)
Bloomberg - Jul 18, 2003
... news. Akzo has turned to cost cutting as its biggest selling drug,
the antidepressant Remeron, loses sales to cheaper generics. ...

Akzo Nobel Shares Rise as Second-Quarter Profit Beats Estimates
Bloomberg - Jul 18, 2003
... news. Akzo has turned to cost cutting as its biggest selling drug,
the antidepressant Remeron, loses sales to cheaper generics. ...

Akzo Nobel unveils a 25% fall in profits
Financial Times (subscription), UK - Jul 18, 2003
... The fall, which was in line with expectations, was mainly a result of cheap generic
competition for Remeron, its antidepressant that has lost its patent ...

Akzo's 2nd-Qtr Profit Sinks 28% as Drug Sales Slip (Update2)
Bloomberg - Jul 18, 2003
... Akzo Nobel NV, the largest Dutch drugmaker, posted a 28 percent decline in second-quarter
profit as cheaper generics eroded sales of its antidepressant Remeron ...

EUROPE MARKETS
CBS MarketWatch - Jul 18, 2003
... Its pharma operating income fell 25 percent due to generic Remeron competition in
the United States, coatings fell 12 percent and chemicals were off 14 percent ...

Akzo Nobel's 2nd-Quarter Profit Sinks 28% as Drug Sales Decline
Bloomberg - Jul 18, 2003
... Akzo Nobel NV, the largest Dutch drugmaker, posted a 28 percent decline in second-quarter
profit as cheaper generics eroded sales of its antidepressant Remeron ...

Akzo Nobel earnings in line with expectations
Pressi.com (press release) - Jul 17, 2003
... currencies and pensions. Pharma sales were impacted by generic competition
to our key drug Remeron in the United States. Net income ...